Study: Cost of developing a new drug tops $1.1 billion

Share this article:

Much has been written about the high cost of drugs. Less has been publicized about how much it costs to get medications to market. Such costs topped $1.1 billion in the 2011-2012 season, according to a new study by Deloitte and Thomson Reuters. That's up $100 million from 2010-2011, based on an examination of a dozen leading firms.

Among the study's findings: The industry has seen a jump in approvals, with 41 between 2011 and 2012, up from 32 between 2010 and 2011. Researchers said the 41 approvals in the 2011-2012 season amounted to $211 billion in projected sales, down from the $309 billion in forecasted sales of the 32 items approved the year before. So while more drugs are getting to market, they are generating smaller returns.

Share this article:

More in Products

Tech Awards deadline extended

The McKnight's Excellence in Technology Awards application deadline has been extended to July 30. The contest honors providers for their efforts to improve resident care.

MasterCare introduces new spa tub solution

MasterCare introduces new spa tub solution

MasterCare has introduced a heated seat to its Entrée "Bath Aire" selection.

MOD introduces new linen truck

MOD introduces new linen truck

Laundry product manufacturer Meese Orbitron Dunne Co. has released the new Poly-Trux® 72ERgonomic bulk linen truck.